Sunosi (solriamfetol) — Medica
Excessive daytime sleepiness associated with obstructive sleep apnea
Preferred products
- modafinil
- armodafinil
Initial criteria
- age ≥ 18 years
- Sunosi will be used in conjunction with positive airway pressure therapy OR patient is unable to initiate or tolerate positive airway pressure therapy
- Positive airway pressure can include CPAP, APAP, or BPAP
- Patient has tried generic modafinil or generic armodafinil
- Exception to step therapy is allowed if patient has previously tried brand Provigil or brand Nuvigil
Approval duration
1 year